International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers

To examine the reproducibility of the single breathhold T2* technique from different scanners, after installation of standard methodology in five international centers.

[1]  John C Wood,et al.  Magnetic resonance imaging measurement of iron overload , 2007, Current opinion in hematology.

[2]  David N. Firmin,et al.  Intercentre Reproducibility of Magnetic Resonance T2* Measurements of Myocardial Iron in Thalassaemia , 2005, The International Journal of Cardiovascular Imaging.

[3]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[4]  D. Pennell,et al.  Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance , 2004, British journal of haematology.

[5]  A. Cnaan,et al.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. , 2004, Haematologica.

[6]  Matthew W. Darlison,et al.  Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[7]  J. Porter.  Practical management of iron overload , 2001, British journal of haematology.

[8]  S. Abbara,et al.  Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major , 2010 .

[9]  D. Pennell,et al.  A single breath‐hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload , 2003, Journal of magnetic resonance imaging : JMRI.

[10]  L. Astrakas,et al.  MRI evaluation of tissue iron burden in patients with β-thalassaemia major , 2007, Pediatric Radiology.

[11]  D. Pennell,et al.  Myocardial T  2* measurements in iron‐overloaded thalassemia: An in vivo study to investigate optimal methods of quantification , 2008, Magnetic resonance in medicine.

[12]  M. Jessup,et al.  Diagnosis and Management of Iron‐induced Heart Disease in Cooley's Anemia , 1998, Annals of the New York Academy of Sciences.

[13]  D J Pennell,et al.  Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major , 2009, Circulation.

[14]  D. Pennell,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Combined Chelation Therapy in Thalassemia Major for the Treatment of Severe Myocardial Siderosis with Left Ventricular Dysfunction , 2008 .

[15]  Mark A Westwood,et al.  Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. , 2006, Haematologica.

[16]  Thomas D. Coates,et al.  Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.

[17]  D. Pennell,et al.  A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance , 2007, Circulation.

[18]  Mark A Westwood,et al.  Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. , 2006, Blood.

[19]  J. Mayet,et al.  The heart in thalassaemia , 2001 .

[20]  D. Pennell,et al.  Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.